Optimized microemulsions and solid microemulsion systems of simvastatin: Characterization and in vivo evaluation

Journal of Pharmaceutical Sciences

Volumn 99, Issue 12, 2010, Pages 4892-4902

  Dixit, Rahul P ^a   Nagarsenker, Mangal S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Colloidal silicon dioxide; Hyperlipidemia; Microemulsion; Simvastatin; Solid microemulsion

Indexed keywords

CHOLESTEROL; SILICON DIOXIDE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; HYPERLIPIDEMIA; IN VIVO STUDY; MICROEMULSION; NONHUMAN; OPTIMIZED MICROEMULSION; PHARMACODYNAMICS; PRECIPITATION; RAT; SCANNING ELECTRON MICROSCOPY; SOLID MICROEMULSION; X RAY DIFFRACTION;

EID: 78049520102     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22208     Document Type: Article

References (38)

1. Kohsaku K, Takayoshi Y, Takashi H, Yoshitaka N, Kazuyoshi M. 2002. Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J Cont Rel 81: 75-82.
2. Tang B, Cheng G, Gu J, Xu C. 2008. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discov Today 13: 606-612.
3. Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. 2001. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 225: 49-62.
4. Rouchotas C, Cassidy O, Rowley G. 2000. Comparison of surface modification and solid dispersion techniques for drug dissolution. Int J Pharm 195: 1-6.
5. Kale R, Saraf M, Tayade P. 2005. Cyclodextrin complexes of valdecoxib: Properties and anti-inflammatory activity in rat. Eur J Pharm Biopharm 60: 39-46.
6. Hammad MA, Muller BW. 1998. Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles. Eur J Pharm Biopharm 46: 361-367.
7. Lawrence MJ, Rees GD. 2000. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45: 89-121.
8. Flanagan J, Singh H. 2006. Microemulsions: A potential delivery system for bioactives in food. Crit Rev Food Sci Nutr 46: 221-237.
9. Gui SY, Wu L, Peng DY, Liu QY, Yin BP, Shen JZ. 2008. Preparation and evaluation of a microemulsion for oral delivery of berberine. Pharmazie 63: 516-519.
10. Nornoo AO, Zheng HA, Lopes LB, Johnson-Restrepo B, Kannan K, Reed R. 2009. Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies. Eur J Pharm Biopharm 71: 310-317.
11. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo JS, Yong CS, Choi HG. 2009. Enhanced oral bioavailability of dexibuprofen by a novel solid SEDDS formulation. Eur J Pharm Biopharm 72: 539-545.
12. Dollo G, Corre PL, Guerin A, Chevanne F, Burgot JR, Verge RL. 2003. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur J Pharm Sci 19: 273-280.
13. Wan YJ, Xu X, Yang H. 2008. A new solid self-micro emulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 70: 439-444.
14. Dollo G, Corre PL, Chevanne F, Verge RL. 2004. Bupivacaine containing dry emulsion can prolong epidural anesthetic effects in rabbits. Eur J Pharm Sci 22: 63-70.
15. Christensen KL, Pedersen GP, Kristensen HG. 2001. Preparation of redispersible dry emulsions by spray drying. Int J Pharm 212: 187-194.
16. Shively ML, Thompson DC. 1995. Oral bioavailability of vancomycin solid-state emulsions. Int J Pharm 117: 119-122.
17. Corveleyn S, Remon JP. 1998. Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm 166: 65-74.
18. Carli F, Chiellini EE, Bellich B, Macchiavelli S, Cadelli G. 2005. Ubidecarenone nanoemulsified composite systems. Int J Pharm 291: 113-118.
19. Farah N, Bouzon J, Rollet M, Taverdet JL, Vergnaud JM. 1987. Dry emulsion-A sustained release dosage form: Modeling of drug transfer in liquids. Int J Pharm 36: 81-88.
20. Dixit RP, Nagarsenker MS. 2008. Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm 34: 1285-1296.
21. Dixit RP, Nagarsenker MS. 2008. Self nanoemulsifying granules of simvastatin: Design, optimization and evaluation. Eur J Pharm Sci 35: 183-192.
22. Christensen KL, Pedersen GP, Kristensen HG. 2002. Physical stability of redispersible dry emulsions containing amorphous sucrose. Eur J Pharm Biopharm 53: 147-153.
23. Heinzelmann K, Franke K. 1999. Using freezing and drying techniques of emulsions for the microencapsulation of fish oil to improve oxidation stability. Colloids Surf B 12: 223-229.
24. Janga DJ, Jeong EJ, Lee HM, Kim BC, Lim SJ, Kim CK. 2006. Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion. Eur J Pharm Sci 28: 405-411.
25. Hansen T, Holmes P, Schultz K. 2004. Process characteristics and compaction of spray dried emulsions containing a drug dissolved in lipid. Int J Pharm 287: 55-66.
26. Agarwal V, Siddiqui A, Ali H, Nazzal S. 2009. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int J Pharm 366: 44-52.
27. Nazzal S, Khan MA. 2006. Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters. Int J Pharm 315: 110-121.
28. Abdalla A, Mäder K. 2007. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm 66: 220-226.
29. Abdalla A, Mäder K. 2009. ESR studies on the influence of physiological dissolution and digestion media on the lipid phase characteristics of SEDDS and SEDDS pellets. Int J Pharm 367: 29-36.
30. Iosio T, Voinovich D, Grassi M, Pinto JF, Perissuttia B, Zacchigna M, Quintavalle U, Serdoz F. 2008. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: Influence of formulation variables and preliminary study on the in vivo absorption. Eur J Pharm Biopharm 69: 686-697.
31. Newton M, Petersson J, Podczeck F, Clarke A, Booth S. 2001. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci 90: 987-995.
32. Dixit RP, Nagarsenker MS. 2007. Dry adsorbed emulsion of simvastatin: Optimization and in vivo advantage. Pharm Dev Tech 12: 495-504.
33. Patil P, Patil V, Paradkar A. 2007. Formulation of self-emulsifying system for oral delivery of SMV: In vitro and in vivo evaluation. Acta Pharm 57: 111-122.
34. Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey AK, Lewis A, Rades T, Prestidge CA. 2009. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol Pharm 6: 861-872.
35. Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. 2009. Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs. J Cont Rel 134: 62-70.
36. Chambin O, Berard V, Rochat-Gonthier MH, Pourcelot Y. 2002. Dry adsorbed emulsion: 2. Dissolution behavior of an intricate formulation. Int J Pharm 235: 169-178.
37. Carlos L, Wasan KM, Sachs-Barrable C, Johnston TP. 2006. Acute p-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression. Pharm Res 23: 1597-1607.
38. Morefield E, Seyer J. 2003. Colloidal silicon dioxide. In: Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of pharmaceutical excipients. 3rd edition. London: The Pharmaceutical Press. pp. 143-145.